Proteolytic enzymes and altered glycosylation modulate dystroglycan function in carcinoma cells

Cancer Research

Volumn 64, Issue 17, 2004, Pages 6152-6159

  Singh, Jarnail ^a   Itahana, Yoko ^a   Knight Krajewski, Selena ^a   Kanagawa, Motoi ^c   Campbell, Kevin P ^c   Bissell, Mina J ^b   Muschler, John ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROGLYCAN; FURIN; LAMININ; METALLOPROTEINASE;

ANIMAL CELL; ARTICLE; BASEMENT MEMBRANE; CANCER CELL; CELL FUNCTION; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; ENZYME GLYCOSYLATION; ENZYME SUBSTRATE; EPITHELIUM CELL; EXTRACELLULAR MATRIX; GLYCOSYLATION; INVASIVE CARCINOMA; MOUSE; MUSCULAR DYSTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN MODIFICATION; PROTEIN PROCESSING;

AMINO ACID SEQUENCE; ANIMALS; BASEMENT MEMBRANE; BREAST NEOPLASMS; CARCINOMA; CELL LINE, TUMOR; COLONIC NEOPLASMS; CYTOSKELETAL PROTEINS; DYSTROGLYCANS; FURIN; GLYCOSYLATION; HUMANS; MEMBRANE GLYCOPROTEINS; METALLOPROTEASES; MICE; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; PROTEIN PROCESSING, POST-TRANSLATIONAL; XENOPUS LAEVIS;

EID: 4344578294     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-1638     Document Type: Article

References (37)

1. Henry MD, Campbell KP. Dystroglycan inside and out. Curr Opin Cell Biol 1999; 11:602-7.
2. Weir ML, Muschler J. Dystroglycan: emerging roles in mammary gland function. J Mammary Gland Biol Neoplasia 2003;8:409-19.
3. Ervasti JM, Campbell KP. Membrane organization of the dystrophinglycoprotein complex. Cell 1991;66:1121-31.
4. Ervasti JM, Campbell KP. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 1993;122:809-23.
5. Cohn RD, Henry MD, Michele DE, et al. Disruption of DAG1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration. Cell 2002; 110:639-48.
6. Moore SA, Saito F, Chen J, et al. Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature (Lond) 2002;418:422-5.
7. Henry MD, Campbell KP. A role for dystroglycan in basement membrane assembly. Cell 1998;95:859-70.
8. Durbeej M, Larsson E, Ibraghimov BO, et al. Non-muscle alpha-dystroglycan is involved in epithelial development. J Cell Biol 1995;130:79-91.
9. Muschler J, Levy D, Boudreau R, et al. A role for dystroglycan in epithelial polarization: loss of function in breast tumor cells. Cancer Res 2002;62:7102-9.
10. Deng WM, Schneider M, Frock R, et al. Dystroglycan is required for polarizing the epithelial cells and the oocyte in Drosophila. Development (Camb) 2003;130:173-84.
11. Rambukkana A, Yamada H, Zanazzi G, et al. Role of alpha-dystroglycan as a Schwann cell receptor for Mycobacterium leprae. Science (Wash DC) 1998;282: 2076-9.
12. Cao W, Henry MD, Borrow P, et al. Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science (Wash DC) 1998;282:2079-81.
13. Michele DE, Campbell KP. Dystrophin-glycoprotein complex: post-translational processing and dystroglycan function. J Biol Chem 2003;278:15457-60.
14. Henry MD, Cohen MB, Campbell KP. Reduced expression of dystroglycan in breast and prostate cancer. Hum Pathol 2001;32:791-5.
15. Chiba A, Matsumura K, Yamada H, et al. Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve alpha-dystroglycan. The role of a novel O-mannosyl-type oligosaccharide in the binding of alpha-dystroglycan with laminin. J Biol Chem 1997;272:2156-62.
16. Michele DE, Barresi R, Kanagawa M, et al. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature (Lond) 2002; 418:417-22.
17. Muntoni F, Brockington M, Torelli S, Brown SC. Defective glycosylation in congenital muscular dystrophies. Curr Opin Neurol 2004;17:205-9.
18. Matsumura K, Chiba A, Yamada H, et al. A role of dystroglycan in schwannoma cell adhesion to laminin. J Biol Chem 1997;272:13904-10.
19. Shimizu H, Hosokawa H, Ninomiya H, Miner JH, Masaki T. Adhesion of cultured bovine aortic endothelial cells to laminin-1 mediated by dystroglycan. J Biol Chem 1999;274:11995-12000.
20. Losasso C, Di Tommaso F, Sgambato A, et al. Anomalous dystroglycan in carcinoma cell lines. FEBS Lett 2000;484:194-8.
21. Sgambato A, Migaldi M, Montanari M, et al. Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression. Am J Pathol 2003;162:849-60.
22. Yamada H, Saito F, Fukuta-Ohi H, et al. Processing of beta-dystroglycan by matrix metalloproteinase disrupts the link between the extracellular matrix and cell membrane via the dystroglycan complex. Hum Mol Genet 2001;10:1563-9.
23. Reichmann E, Ball R, Groner B, Friis RR. New mammary epithelial and fibroblastic cell clones in coculture form structures competent to differentiate functionally. J Cell Biol 1989;108:1127-38.
24. Oft M, Peli J, Rudaz C, et al. TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev 1996;10: 2462-77.
25. Komada M, Hatsuzawa K, Shibamoto S, et al. Proteolytic processing of the hepatocyte growth factor/scatter factor receptor by furin. FEBS Lett 1993;328:25-9.
26. Bozzi M, Veglia G, Paci M, et al. A synthetic peptide corresponding to the 550-585 region of alpha-dystroglycan binds beta-dystroglycan as revealed by NMR spectroscopy. FEBS Lett 2001;499:210-4.
27. Thomas G. Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat Rev Mol Cell Biol 2002;3:753-66.
28. Dubois CM, Blanchette F, Laprise MH, et al. Evidence that furin is an authentic transforming growth factor-beta1-converting enzyme. Am J Pathol 2001;158:305-16.
29. Durbeej M, Henry MD, Ferletta M, Campbell KP, Ekblom P. Distribution of dystroglycan in normal adult mouse tissues. J Histochem Cytochem 1998;46:449-57.
30. Takahashi S, Nakagawa T, Kasai K, et al. A second mutant allele of furin in the processing-incompetent cell line, LoVo. Evidence for involvement of the homo B domain in autocatalytic activation. J Biol Chem 1995;270:26565-9.
31. Bozic D, Engel J, Brancaccio A. Sequence analysis suggests the presence of an IG-like domain in the N-terminal region of alpha-dystroglycan which was crystallized after mutation of a protease susceptible site (Arg168→His). Matrix Biol 1998;17: 495-500.
32. Kunz S, Sevilla N, McGavern DB, Campbell KP, Oldstone MB. Molecular analysis of the interaction of LCMV with its cellular receptor [alpha]-dystroglycan. J Cell Biol 2001;155:301-10.
33. Duclos F, Straub V, Moore SA, et al. Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice. J Cell Biol 1998;142:1461-71.
34. Holt KH, Crosbie RH, Venzke DP, Campbell KP. Biosynthesis of dystroglycan: processing of a precursor propeptide. FEBS Lett 2000;468:79-83.
35. Durbeej M, Campbell KP. Biochemical characterization of the epithelial dystroglycan complex. J Biol Chem 1999;274:26609-16.
36. Bassi DE, Mahloogi H, Lopez De Cicco R, Klein-Szanto A. Increased furin activity enhances the malignant phenotype of human head and neck cancer cells. Am J Pathol 2003;162:439-47.
37. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002;2:161-74.